World's Best Scientists 2026 revealed!
VIEW LIST
David A. Reardon

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 126 2928 2732 1623 1493 697 66824

David A. Reardon publications per year

The chart shows the history of publications by David A. Reardon between 1986 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David A. Reardon published across 40 years, from 1986 to 2025, averaging 30 papers a year. Output peaked at 279 publications in 2023. 164 of the 1,199 publications appeared in the last two years.

No. of publications
50 100 150 200 250
Bar chart. Horizontal axis: year, 1986 to 2025. Vertical axis: number of publications, 0 to 279. Peak 279 publications in 2023. 1986: 1 publication 1987: 0 publications 1988: 1 publication 1989: 0 publications 1990: 1 publication 1991: 1 publication 1992: 1 publication 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 1 publication 1998: 6 publications 1999: 8 publications 2000: 4 publications 2001: 2 publications 2002: 3 publications 2003: 4 publications 2004: 11 publications 2005: 15 publications 2006: 20 publications 2007: 28 publications 2008: 28 publications 2009: 33 publications 2010: 34 publications 2011: 40 publications 2012: 28 publications 2013: 28 publications 2014: 51 publications 2015: 64 publications 2016: 41 publications 2017: 41 publications 2018: 58 publications 2019: 38 publications 2020: 48 publications 2021: 57 publications 2022: 60 publications 2023: 279 publications 2024: 83 publications 2025: 81 publications
1986 2025

1,199 publications in total across all disciplines

View publications per year as a table
David A. Reardon: publications per year, 1986 to 2025
Year Publications
1986 1
1987 0
1988 1
1989 0
1990 1
1991 1
1992 1
1993 0
1994 0
1995 0
1996 0
1997 1
1998 6
1999 8
2000 4
2001 2
2002 3
2003 4
2004 11
2005 15
2006 20
2007 28
2008 28
2009 33
2010 34
2011 40
2012 28
2013 28
2014 51
2015 64
2016 41
2017 41
2018 58
2019 38
2020 48
2021 57
2022 60
2023 279
2024 83
2025 81
Total 1,199
Download as CSV

David A. Reardon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David A. Reardon sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 681–700 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 697 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336 697
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

David A. Reardon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David A. Reardon sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 126–127 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252 126
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

David A. Reardon is affiliated with Harvard University in the United States. The primary fields of study in their research include Medicine and Biochemistry, Genetics and Molecular Biology. Their work extensively covers subfields such as Genetics, Oncology, Pulmonary and Respiratory Medicine, Immunology, and Molecular Biology.

The main research topics addressed by David A. Reardon are:

  • Glioma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Radiomics and Machine Learning in Medical Imaging
  • Brain Metastases and Treatment
  • Immunotherapy and Immune Responses
  • Cancer Research and Treatments

Key recent papers authored or co-authored by David A. Reardon include:

  • Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma, 2020, JAMA Oncology
  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions, 2020, Neuro-Oncology
  • Mechanisms and therapeutic implications of hypermutation in gliomas, 2020, Nature
  • Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter, 2022, Neuro-Oncology
  • Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial, 2022, Neuro-Oncology

The scientist frequently collaborates with the following colleagues:

  • Patrick Y. Wen
  • Eudocia Q. Lee
  • Keith L. Ligon
  • Wenya Linda Bi
  • Ugonma Chukwueke

David A. Reardon's research has been published mainly in the following venues:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Neuro-Oncology Advances
  • Clinical Cancer Research
  • ONCOLOGY

Their work is noted for its involvement in oncology with a strong focus on glioma and glioblastoma treatments, integrating immunotherapy approaches and exploring biomarkers. The research contributions also extend to the development of therapeutic strategies involving CAR-T cell therapy and radiomics applied in medical imaging.

Best Publications

  • IDH1 and IDH2 Mutations in Gliomas

    Hai Yan;D. Williams Parsons;Genglin Jin;Roger McLendon

  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

    Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy

  • Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

    James J. Vredenburgh;Annick Desjardins;James E. Herndon;Jennifer Marcello

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

    James J. Vredenburgh;Annick Desjardins;James E. Herndon;Jeannette M. Dowell

  • Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

    Hussein A. Tawbi;Peter A. Forsyth;Alain Algazi;Omid Hamid

  • Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

    Timothy F. Cloughesy;Aaron Y. Mochizuki;Joey R. Orpilla;Willy Hugo

  • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge

  • Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial

    David A. Reardon;Alba A. Brandes;Antonio Omuro;Paul Mulholland

  • Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

    John H. Sampson;Amy B Heimberger;Gary E. Archer;Kenneth D. Aldape

  • Phase II Trial of Gefitinib in Recurrent Glioblastoma

    Jeremy N. Rich;David A. Reardon;Terry Peery;Jeannette M. Dowell

  • Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    Patrick Y. Wen;Michael Weller;Eudocia Quant Lee;Brian M. Alexander

  • Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

    Hideho Okada;Michael Weller;Raymond Huang;Gaetano Finocchiaro

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

    M. J. van den Bent;J. S. Wefel;D. Schiff;M. J. B. Taphoorn

  • Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

    Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang

  • Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

    David A. Reardon;Karen L. Fink;Tom Mikkelsen;Timothy F. Cloughesy

  • Molecular targeted therapy of glioblastoma

    Emilie Le Rhun;Matthias Preusser;Patrick Roth;David A. Reardon

  • Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

    Antonio Omuro;Gordana Vlahovic;Michael Lim;Solmaz Sahebjam

  • Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

    Michael R. Zalutsky;David A. Reardon;Gamal Akabani;R. Edward Coleman

Frequent Co-Authors

Patrick Y. Wen
Patrick Y. Wen Harvard University
James J. Vredenburgh
James J. Vredenburgh Yale School of Medicine
Henry S. Friedman
Henry S. Friedman Duke University
Keith L. Ligon
Keith L. Ligon Harvard University
John H. Sampson
John H. Sampson Duke University
James E. Herndon
James E. Herndon Duke University
Allan H. Friedman
Allan H. Friedman Duke University
Darell D. Bigner
Darell D. Bigner Duke University
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Jeremy N. Rich
Jeremy N. Rich University of Pittsburgh

External Links

Personal website of David A. Reardon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online programs can open new pathways in medicine and healthcare, especially for those seeking flexibility or faster entry into the field. For students looking to enter nursing quickly, fast lpn program options offer streamlined routes to licensure. These courses compress traditional curricula, helping you qualify sooner for hands-on roles in patient care.

Mental health is an area of growing demand. If you hold a master’s degree in nursing, you might consider the fastest post master's pmhnp programs online. These programs let you specialize as a psychiatric mental health nurse practitioner and could expand your career in a critical area of healthcare.

Leadership and administration roles are also accessible with online studies. Pursuing a health care administration online degree can prepare you for managerial positions within clinics, hospitals, or other organizations. If cost is a key concern, search for the cheapest online master degree in healthcare administration to ensure your education is both affordable and impactful.

These online degrees provide flexible and affordable paths to rewarding roles across the healthcare sector.

Best Scientists Citing David A. Reardon

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 230

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 223

Michael Weller

Michael Weller

University of Zurich

Publications: 222

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 155

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 155

Mark R. Gilbert

Mark R. Gilbert

National Institutes of Health

Publications: 123

John H. Sampson

John H. Sampson

Duke University

Publications: 119

Roger Stupp

Roger Stupp

Northwestern University

Publications: 108

Darell D. Bigner

Darell D. Bigner

Duke University

Publications: 107

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 107

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 105

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 103

Karl-Josef Langen

Karl-Josef Langen

Forschungszentrum Jülich

Publications: 92

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 91

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 83

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 82

Trending Scientists

Christos D. Malliakas

Christos D. Malliakas

Northwestern University

Hossam E. Emam

Hossam E. Emam

National Research Center, Cairo

J.A. Van Wyk

J.A. Van Wyk

University of Pretoria

Phee Lep Yeoh

Phee Lep Yeoh

University of Sydney

Iven Mareels

Iven Mareels

IBM (United States)

Charles E. Schroeder

Charles E. Schroeder

Nathan Kline Institute for Psychiatric Research

Bente Vilsen

Bente Vilsen

Aarhus University

Wolfgang Maier

Wolfgang Maier

Cardiff University

Kazuro Hirahara

Kazuro Hirahara

RIKEN Center for Advanced Intelligence Project

Stephen P. Borgatti

Stephen P. Borgatti

University of Kentucky

Paloma Campo

Paloma Campo

Instituto de Salud Carlos III

Jennie Si

Jennie Si

Arizona State University

James K. McCusker

James K. McCusker

Michigan State University

Chris Alden

Chris Alden

London School of Economics and Political Science

Martin P Eccles

Martin P Eccles

Newcastle University

Martin Vohralík

Martin Vohralík

French Institute for Research in Computer Science and Automation - INRIA

Related Medicine Rankings & Guides

2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs
2027 Cost of LPN Programs & Schools

2027 Cost of LPN Programs & Schools
2027 Most Affordable Online Medical Assistant Programs

2027 Most Affordable Online Medical Assistant Programs
September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs

September 2027 Best Online Doctorate in Pharmacy (PharmD.) Programs
2027 Easiest LPN Programs to Get Into

2027 Easiest LPN Programs to Get Into
2027 Most Affordable Master’s Degrees in Healthcare Administration

2027 Most Affordable Master’s Degrees in Healthcare Administration
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus
2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference

2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Most Affordable Online MSN in Nurse Executive Leadership Programs

2027 Most Affordable Online MSN in Nurse Executive Leadership Programs
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs
2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus
2027 Medical Lab Tech Programs Online: Best Schools

2027 Medical Lab Tech Programs Online: Best Schools
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
2027 Fastest Online MSN in Nurse Midwifery Programs

2027 Fastest Online MSN in Nurse Midwifery Programs
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Best Online Pharmacy Technician Associate Programs

2027 Best Online Pharmacy Technician Associate Programs
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Easiest Nurse Practitioner Specialty Programs to Get Into

2027 Easiest Nurse Practitioner Specialty Programs to Get Into

Recently Published Articles

2027 How to Become a Special Education Teacher in North Las Vegas, NV: Education Requirements & Certification

2027 How to Become a Special Education Teacher in North Las Vegas, NV: Education Requirements & Certification
2027 Fastest Growing Psychology Major Jobs

2027 Fastest Growing Psychology Major Jobs
2027 What Can You Do with an MBA in Information Technology? Costs & Opportunities

2027 What Can You Do with an MBA in Information Technology? Costs & Opportunities
2027 Nurse Practitioner vs. Doctor for Primary Care: Explaining the Difference

2027 Nurse Practitioner vs. Doctor for Primary Care: Explaining the Difference
2027 How To Become an LVN in California

2027 How To Become an LVN in California
2027 How to Become an Ultrasound Technician in Mississippi

2027 How to Become an Ultrasound Technician in Mississippi
2027 Associate to Bachelor's in Software Engineering: Transfer Pathways Explained

2027 Associate to Bachelor's in Software Engineering: Transfer Pathways Explained
2027 How to Become a Special Education Teacher in Las Vegas, NV: Education Requirements & Certification

2027 How to Become a Special Education Teacher in Las Vegas, NV: Education Requirements & Certification
2027 Can You Complete an Online Clinical Mental Health Counseling Degree Program While Working Full-Time?

2027 Can You Complete an Online Clinical Mental Health Counseling Degree Program While Working Full-Time?
2027 What Careers Can You Pursue With a Biology Degree? Salary Potential, Job Outlook, and Next Steps

2027 What Careers Can You Pursue With a Biology Degree? Salary Potential, Job Outlook, and Next Steps
2027 Is a 2-Year Aviation Management Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs

2027 Is a 2-Year Aviation Management Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs
2027 Best Nursing Schools in Spokane, WA – Accredited Nursing Degree Programs Online

2027 Best Nursing Schools in Spokane, WA – Accredited Nursing Degree Programs Online
2027 Is Animation a Hard Major? What Students Should Know

2027 Is Animation a Hard Major? What Students Should Know
2027 Reading & Literacy Degree Jobs That Do Not Require Licensure

2027 Reading & Literacy Degree Jobs That Do Not Require Licensure
2027 BCBA Career Guide for Human Services Majors

2027 BCBA Career Guide for Human Services Majors
2027 Rhode Island Nursing License Requirements

2027 Rhode Island Nursing License Requirements
2027 How to Become an OB-GYN Sonographer: Education, Salary, and Job Outlook

2027 How to Become an OB-GYN Sonographer: Education, Salary, and Job Outlook
2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply

2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply
2027 Best Behavioral Health Leadership Degrees for Working Adults

2027 Best Behavioral Health Leadership Degrees for Working Adults
2027 Engineering Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Engineering Degree Coursework Explained: What Classes Can You Expect to Take?
2027 What Job Postings Reveal About Game Design Careers: Skills, Degrees, and Experience Employers Want

2027 What Job Postings Reveal About Game Design Careers: Skills, Degrees, and Experience Employers Want